Results: << | 201-225 | 226-250 | 251-275 | 276-300 | >>

Table of contents of journal: *Alimentary pharmacology and therapeutics

Results: 201-225/1697

Authors: Dinan, TG Mahmud, N Rathore, O Thakore, J Scott, LV Carr, E Naesdal, J O'Morain, CA Keeling, PWN
Citation: Tg. Dinan et al., A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia - are central serotoninergic responses enhanced?, ALIM PHARM, 15(10), 2001, pp. 1613-1618

Authors: Carroccio, A Guarino, A Zuin, G Verghi, F Canani, RB Fontana, M Bruzzese, E Montalto, G Notarbartolo, A
Citation: A. Carroccio et al., Efficacy of oral pancreatic enzyme therapy for the treatment of fat malabsorption in HIV-infected patients, ALIM PHARM, 15(10), 2001, pp. 1619-1625

Authors: Hernandez, LV Gilson, I Jacobson, J Affi, A Puetz, TR Dindzans, VJ
Citation: Lv. Hernandez et al., Antiretroviral hepatotoxicity in human immunodeficiency virus-infected patients, ALIM PHARM, 15(10), 2001, pp. 1627-1632

Authors: Hui, CK Lai, KC Yuen, MF Ng, M Lai, CL Lam, SK
Citation: Ck. Hui et al., Acute cholangitis - predictive factors for emergency ERCP, ALIM PHARM, 15(10), 2001, pp. 1633-1637

Authors: Arnott, IDR McDonald, D Williams, A Ghosh, S
Citation: Idr. Arnott et al., Clinical use of Infliximab in Crohn's disease: the Edinburgh experience, ALIM PHARM, 15(10), 2001, pp. 1639-1646

Authors: Van Den Bogaerde, J Kamm, MA Knight, SC
Citation: J. Van Den Bogaerde et al., Immune sensitization to food, yeast and bacteria in Crohn's disease, ALIM PHARM, 15(10), 2001, pp. 1647-1653

Authors: Muller-Lissner, SA Fumagalli, I Bardhan, KD Pace, F Pecher, E Nault, B Ruegg, P
Citation: Sa. Muller-lissner et al., Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation, ALIM PHARM, 15(10), 2001, pp. 1655-1666

Authors: Hasegawa, T Yoneda, M Nakamura, K Makino, I Terano, A
Citation: T. Hasegawa et al., Plasma transforming growth factor-beta 1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study, ALIM PHARM, 15(10), 2001, pp. 1667-1672

Authors: Netzer, P Domek, M Pai, R Halter, F Tarnawski, A
Citation: P. Netzer et al., Inhibition of human colon cancer cell growth by antisense oligodeoxynucleotides targeted at basic fibroblast growth factor, ALIM PHARM, 15(10), 2001, pp. 1673-1679

Authors: Sasaki, M Fitzgerald, AJ Mandir, N Sasaki, K Wright, NA Goodlad, RA
Citation: M. Sasaki et al., Glicentin, an active enteroglucagon, has a significant trophic role on thesmall intestine but not on the colon in the rat, ALIM PHARM, 15(10), 2001, pp. 1681-1686

Authors: Dotan, I Hershkoviz, R Karmeli, F Brazowski, E Peled, Y Rachmilewitz, D Halpern, Z
Citation: I. Dotan et al., Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats, ALIM PHARM, 15(10), 2001, pp. 1687-1697

Authors: Hawkey, CJ Jackson, L Harper, SE Simon, TJ Mortensen, E Lines, CR
Citation: Cj. Hawkey et al., The gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans, ALIM PHARM, 15(1), 2001, pp. 1-9

Authors: Gotteland, M Cruchet, S Verbeke, S
Citation: M. Gotteland et al., Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans, ALIM PHARM, 15(1), 2001, pp. 11-17

Authors: Chan, FKL Sung, JJY Ching, JYL Wu, JCY Lee, YT Leung, WK Hui, Y Chan, LY Lai, ACW Chung, SCS
Citation: Fkl. Chan et al., Randomized trial of low-dose misoprostol and naproxen vs. nabumetone to prevent recurrent upper gastrointestinal haemorrhage in users of non-steroidal anti-inflammatory drugs, ALIM PHARM, 15(1), 2001, pp. 19-24

Authors: To, KF Chan, FKL Cheng, ASL Lee, TL Ng, YP Sung, JJY
Citation: Kf. To et al., Up-regulation of cyclooxygenase-1 and-2 in human gastric ulcer, ALIM PHARM, 15(1), 2001, pp. 25-34

Authors: Chong, RY Hanauer, SB Cohen, RD
Citation: Ry. Chong et al., Efficacy of parenteral methotrexate in refractory Crohn's disease, ALIM PHARM, 15(1), 2001, pp. 35-44

Authors: Lundin, P Naber, T Nilsson, M Edsbacker, S
Citation: P. Lundin et al., Effect of food on the pharmacokinetics of budesonide controlled ileal release capsules in patients with active Crohn's disease, ALIM PHARM, 15(1), 2001, pp. 45-51

Authors: Hussain, FN Ajjan, RA Kapur, K Moustafa, M Riley, SA
Citation: Fn. Hussain et al., Once versus divided daily dosing with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters, ALIM PHARM, 15(1), 2001, pp. 53-62

Authors: Scheiman, JM Bandekar, RR Chernew, ME Fendrick, AM
Citation: Jm. Scheiman et al., Helicobacter pylori screening for individuals requiring chronic NSAID therapy: a decision analysis, ALIM PHARM, 15(1), 2001, pp. 63-71

Authors: Manes, G Balzano, A Iaquinto, G Ricci, C Piccirillo, MM Giardullo, N Todisco, A Lioniello, M Vaira, D
Citation: G. Manes et al., Accuracy of the stool antigen test in the diagnosis of Helicobacter pyloriinfection before treatment and in patients on omeprazole therapy, ALIM PHARM, 15(1), 2001, pp. 73-79

Authors: Xiao, SD Liu, WZ Hu, PJ Ouyang, Q Wang, JL Zhou, LY Cheng, NN
Citation: Sd. Xiao et al., A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China, ALIM PHARM, 15(1), 2001, pp. 81-86

Authors: Hirschowitz, BI Haber, MM
Citation: Bi. Hirschowitz et Mm. Haber, Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole, ALIM PHARM, 15(1), 2001, pp. 87-103

Authors: Bell, N Karol, MD Sachs, G Greski-Rose, P Jennings, DE Hunt, RH
Citation: N. Bell et al., Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers, ALIM PHARM, 15(1), 2001, pp. 105-113

Authors: Perkins, AC Wilson, CG Frier, M Blackshaw, PE Juan, D Dansereau, RJ Hathaway, S Li, Z Long, P Spiller, RC
Citation: Ac. Perkins et al., Oesophageal transit, disintegration and gastric emptying of a film-coated risedronate placebo tablet in gastro-oesophageal reflux disease and normal control subjects, ALIM PHARM, 15(1), 2001, pp. 115-121

Authors: Petroni, ML Jazrawi, RP Pazzi, P Lanzini, A Zuin, M Pigozzi, MG Fracchia, M Galatola, G Alvisi, V Heaton, KW Podda, M Northfield, TC
Citation: Ml. Petroni et al., Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial, ALIM PHARM, 15(1), 2001, pp. 123-128
Risultati: << | 201-225 | 226-250 | 251-275 | 276-300 | >>